Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genomic Health Inc (NASDAQ:GHDX)

Delayed Data
As of Jan 20
 +0.35 / +1.29%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Genomic Health Inc have a median target of 32.50, with a high estimate of 39.50 and a low estimate of 27.00. The median estimate represents a +17.84% increase from the last price of 27.58.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Hold stock in Genomic Health Inc. This rating has held steady since January, when it was downgraded from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 97.53%
Growthannually 55.60%


Growthquarterly 2.24%
Growthannually 14.83%
Key to the earnings and sales forecast charts.